BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29355901)

  • 1. Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
    Zimmaro LA; Sephton SE; Siwik CJ; Phillips KM; Rebholz WN; Kraemer HC; Giese-Davis J; Wilson L; Bumpous JM; Cash ED
    Cancer; 2018 Mar; 124(5):1053-1060. PubMed ID: 29355901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive symptoms and actigraphy-measured circadian disruption predict head and neck cancer survival.
    Cash E; Duck CR; Brinkman C; Rebholz W; Albert C; Worthen M; Jusufbegovic M; Wilson L; Bumpous JM
    Psychooncology; 2018 Oct; 27(10):2500-2507. PubMed ID: 30117225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive Symptoms, Systemic Inflammation, and Survival Among Patients With Head and Neck Cancer.
    Cash E; Albert C; Palmer I; Polzin B; Kabithe A; Crawford D; Bumpous JM; Sephton SE
    JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):405-413. PubMed ID: 38546616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment depression as a prognostic indicator of survival and nutritional status in patients with head and neck cancer.
    Kim SA; Roh JL; Lee SA; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Cancer; 2016 Jan; 122(1):131-40. PubMed ID: 26371775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study.
    Jansen F; Verdonck-de Leeuw IM; Cuijpers P; Leemans CR; Waterboer T; Pawlita M; Penfold C; Thomas SJ; Waylen A; Ness AR
    Psychooncology; 2018 Sep; 27(9):2245-2256. PubMed ID: 29927013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.
    Kano S; Homma A; Hatakeyama H; Mizumachi T; Sakashita T; Kakizaki T; Fukuda S
    Head Neck; 2017 Feb; 39(2):247-253. PubMed ID: 27617428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen".
    Gamez ME; Agarwal M; Hu KS; Lukens JN; Harrison LB
    Anticancer Res; 2017 Feb; 37(2):685-691. PubMed ID: 28179317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
    Van den Wyngaert T; Helsen N; Carp L; Hakim S; Martens MJ; Hutsebaut I; Debruyne PR; Maes ALM; van Dinther J; Van Laer CG; Hoekstra OS; De Bree R; Meersschout SAE; Lenssen O; Vermorken JB; Van den Weyngaert D; Stroobants S;
    J Clin Oncol; 2017 Oct; 35(30):3458-3464. PubMed ID: 28854069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mood and malignancy: head and neck cancer and depression.
    Archer J; Hutchison I; Korszun A
    J Oral Pathol Med; 2008 May; 37(5):255-70. PubMed ID: 18312300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
    Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
    Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?
    Choi SH; Terrell JE; Bradford CR; Ghanem T; Spector ME; Wolf GT; Lipkus IM; Duffy SA
    Nicotine Tob Res; 2016 Dec; 18(12):2216-2224. PubMed ID: 27613928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized outcome prognostication for patients with laryngeal cancer.
    Hoban CW; Beesley LJ; Bellile EL; Sun Y; Spector ME; Wolf GT; Taylor JMG; Shuman AG
    Cancer; 2018 Feb; 124(4):706-716. PubMed ID: 29112231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
    Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
    Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment at high-volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer.
    David JM; Ho AS; Luu M; Yoshida EJ; Kim S; Mita AC; Scher KS; Shiao SL; Tighiouart M; Zumsteg ZS
    Cancer; 2017 Oct; 123(20):3933-3942. PubMed ID: 28640546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Endoscopic Gastrostomy Tube Is a Negative Prognostic Factor for Recurrent/Metastatic Head and Neck Cancer.
    Siano M; Jarisch N; Joerger M; Espeli V
    Anticancer Res; 2018 Jun; 38(6):3725-3729. PubMed ID: 29848734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis.
    Stokes WA; Amini A; Jones BL; McDermott JD; Raben D; Ghosh D; Goddard JA; Bowles DW; Karam SD
    Head Neck; 2017 Jun; 39(6):1113-1121. PubMed ID: 28301079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment Dysphagia Inventory and videofluorographic swallowing study as prognostic indicators of early survival outcomes in head and neck cancer.
    Yang CJ; Roh JL; Choi KH; Kim MJ; Choi SH; Nam SY; Kim SY
    Cancer; 2015 May; 121(10):1588-98. PubMed ID: 25639759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of psychosocial distress on outcome for head and neck cancer patients undergoing radiation.
    Chen AM; Hsu S; Felix C; Garst J; Yoshizaki T
    Laryngoscope; 2018 Mar; 128(3):641-645. PubMed ID: 28714543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.